aCGH helps detect cancer types by analyzing chromosome abnormalities, aiding accurate diagnosis and targeted treatment, especially in CUP cases.
Menu
aCGH helps detect cancer types by analyzing chromosome abnormalities, aiding accurate diagnosis and targeted treatment, especially in CUP cases.
RGCC array Comparative Genomic Hybridization (aCGH) test reveals the structural abnormalities present within the genome. It is a cytogenetic assay used for the detection of chromosomal abnormalities. It is an easy and quick method requiring CTCs from a patient blood sample.
Through advanced comparative genome hybridization techniques, this test offers invaluable insights into the patient’s genetic makeup, RGCC aCGH scrutinizes the patient’s DNA for abnormalities and malfunctions, providing personalized chromosomal analysis results, and guiding clinical decisions with precision to find the primary origin of the tumour.
aCGH, array Comparative Genomic Hybridization test designed to identify the location of the primary tumor and detect chromosomal abnormalities helps identify chromosomal abnormalities associated with specific types of cancer. The test is used to detect carcinoma of unknown primary origin.
The first step towards personalized cancer care is scheduling an appointment with us.
Upon booking the appointment, you get a consultation with our RGCC experts to assess your cancer status.
We guide you through the process of selecting the most effective tests for your specific cancer.
We deliver precise results that guide treatment decisions and enhance outcomes.
“With RGCC’s aCGH test, I can predict primary tumor location from multiple tumours through genetic abnormalities. This information is crucial for primary treatment planning, ensuring optimal outcomes and patient well-being. A vital tool in modern oncology.”
Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.
RGCC aCGH test is performed to identify the abnormalities in chromosomes that are associated with different types of cancer.
Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.
Still unsure about the location of your tumor? aCGH is the right test for you! This test detects chromosomal abnormalities to reveal the location of your tumor. Take the aCGH test today and gain clarity on your cancer diagnosis.
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
© 2025 Neeli Genetics. All Rights Reserved.